Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: January 24, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for HKI-357

Email this page to a colleague

« Back to Dashboard

What is the drug development status for HKI-357?

HKI-357 is an investigational drug.

There have been 22 clinical trials for HKI-357. The most recent clinical trial was a Phase 3 trial, which was initiated on July 9^th 2009.

The most common disease conditions in clinical trials are Breast Neoplasms, Neoplasms, and Brain Neoplasms. The leading clinical trial sponsors are Puma Biotechnology, Inc., Wyeth is now a wholly owned subsidiary of Pfizer, and NSABP Foundation Inc.

Summary for HKI-357

US Patents	0
International Patents	0
US Patent Applications	87
WIPO Patent Applications	65
Japanese Patent Applications	30
Clinical Trial Progress	Phase 3 (2009-07-09)
Vendors	26

Recent Clinical Trials for HKI-357

Title	Sponsor	Phase
HKI-272 for HER2-Positive Breast Cancer and Brain Metastases	Puma Biotechnology, Inc.	Phase 2
HKI-272 for HER2-Positive Breast Cancer and Brain Metastases	Translational Breast Cancer Research Consortium	Phase 2
HKI-272 for HER2-Positive Breast Cancer and Brain Metastases	Dana-Farber Cancer Institute	Phase 2

See all HKI-357 clinical trials

Clinical Trial Summary for HKI-357

Top disease conditions for HKI-357

Top clinical trial sponsors for HKI-357

See all HKI-357 clinical trials

US Patents for HKI-357

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
>Drugname	>Patent Number	>Patent Title	>Patent Assignee	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon

Medtronic

Mallinckrodt

McKesson

Johnson and Johnson

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.